ATE98689T1 - Immobilisierungsverfahren. - Google Patents
Immobilisierungsverfahren.Info
- Publication number
- ATE98689T1 ATE98689T1 AT88306038T AT88306038T ATE98689T1 AT E98689 T1 ATE98689 T1 AT E98689T1 AT 88306038 T AT88306038 T AT 88306038T AT 88306038 T AT88306038 T AT 88306038T AT E98689 T1 ATE98689 T1 AT E98689T1
- Authority
- AT
- Austria
- Prior art keywords
- immobilization procedure
- immobilization
- polyazetidine
- coenzymes
- dewatering
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
- C12N11/08—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
- C12N11/089—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- C12N11/091—Phenol resins; Amino resins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
- C12N11/08—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
- C12N11/089—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
- C12N11/08—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
- C12N11/098—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer formed in the presence of the enzymes or microbial cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/90—Isomerases (5.)
- C12N9/92—Glucose isomerase (5.3.1.5; 5.3.1.9; 5.3.1.18)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Saccharide Compounds (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK336987A DK336987D0 (da) | 1987-07-01 | 1987-07-01 | Immobiliseringsmetode |
| EP88306038A EP0297912B1 (de) | 1987-07-01 | 1988-06-30 | Immobilisierungsverfahren |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE98689T1 true ATE98689T1 (de) | 1994-01-15 |
Family
ID=8122094
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT88306038T ATE98689T1 (de) | 1987-07-01 | 1988-06-30 | Immobilisierungsverfahren. |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP0297912B1 (de) |
| JP (1) | JP2641934B2 (de) |
| KR (1) | KR970000186B1 (de) |
| AT (1) | ATE98689T1 (de) |
| DE (1) | DE3886280T2 (de) |
| DK (2) | DK336987D0 (de) |
| ES (1) | ES2061656T3 (de) |
| WO (1) | WO1989000195A1 (de) |
Families Citing this family (84)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI85384C (fi) * | 1989-09-06 | 1992-04-10 | Cultor Oy | Foerfarande foer hydrolysering av hemicellulosa med immobiliserade enzymer och produkt som omfattar ett immobiliserat hemicellulolytiskt enzym. |
| DK589389D0 (da) * | 1989-11-23 | 1989-11-23 | Novo Nordisk As | Immobiliseret enzympraeparat |
| AT401653B (de) * | 1994-10-05 | 1996-11-25 | Avl Verbrennungskraft Messtech | Verfahren zur immobilisierung biologischer komponenten in einer polymermatrix sowie biosensoren unter verwendung derartiger immobilisate |
| WO1997004086A1 (en) * | 1995-07-18 | 1997-02-06 | Gist-Brocades B.V. | An improved immobilized penicillin g acylase |
| US6060268A (en) * | 1995-07-18 | 2000-05-09 | Gist-Brocades B.V. | Penicillin G acylase immobilized with a crosslinked mixture of gelled gelatin and amino polymer |
| GB0013810D0 (en) | 2000-06-06 | 2000-07-26 | Celltech Chiroscience Ltd | Biological products |
| GB0303337D0 (en) | 2003-02-13 | 2003-03-19 | Celltech R&D Ltd | Biological products |
| PT1960430E (pt) | 2005-12-09 | 2015-01-05 | Ucb Pharma Sa | Moléculas de anticorpo com especificidade para il-6 humana |
| GB0620729D0 (en) | 2006-10-18 | 2006-11-29 | Ucb Sa | Biological products |
| GB0807413D0 (en) | 2008-04-23 | 2008-05-28 | Ucb Pharma Sa | Biological products |
| WO2010096418A2 (en) | 2009-02-17 | 2010-08-26 | Ucb Pharma S.A. | Antibody molecules having specificity for human ox40 |
| GB0904214D0 (en) | 2009-03-11 | 2009-04-22 | Ucb Pharma Sa | Biological products |
| WO2011030107A1 (en) | 2009-09-10 | 2011-03-17 | Ucb Pharma S.A. | Multivalent antibodies |
| GB0920127D0 (en) | 2009-11-17 | 2009-12-30 | Ucb Pharma Sa | Antibodies |
| GB0920324D0 (en) | 2009-11-19 | 2010-01-06 | Ucb Pharma Sa | Antibodies |
| GB201000467D0 (en) | 2010-01-12 | 2010-02-24 | Ucb Pharma Sa | Antibodies |
| CN102892786B (zh) | 2010-03-11 | 2016-03-16 | Ucb医药有限公司 | Pd-1抗体 |
| TW201134488A (en) | 2010-03-11 | 2011-10-16 | Ucb Pharma Sa | PD-1 antibodies |
| GB201005064D0 (en) | 2010-03-25 | 2010-05-12 | Ucb Pharma Sa | Biological products |
| WO2011117653A1 (en) | 2010-03-25 | 2011-09-29 | Ucb Pharma S.A. | Disulfide stabilized dvd-lg molecules |
| GB201014033D0 (en) | 2010-08-20 | 2010-10-06 | Ucb Pharma Sa | Biological products |
| EP3219728A1 (de) | 2011-01-14 | 2017-09-20 | UCB Biopharma SPRL | Antikörpermodule zur bindung an il-17a und il-17f |
| SI2758432T1 (sl) | 2011-09-16 | 2019-07-31 | Ucb Biopharma Sprl | Nevtralizirajoča protitelesa proti glavnim eksotoksinom TCDA in TCDB iz clostridium difficile |
| UA112203C2 (uk) | 2011-11-11 | 2016-08-10 | Юсб Фарма С.А. | Злитий білок біоспецифічного антитіла, який зв'язується з ox40 людини та сироватковим альбуміном людини |
| GB201203071D0 (en) | 2012-02-22 | 2012-04-04 | Ucb Pharma Sa | Biological products |
| GB201203051D0 (en) | 2012-02-22 | 2012-04-04 | Ucb Pharma Sa | Biological products |
| GB201208370D0 (en) | 2012-05-14 | 2012-06-27 | Ucb Pharma Sa | Antibodies |
| CN102758289A (zh) * | 2012-08-06 | 2012-10-31 | 天津工业大学 | 一种用于细胞固定化的机织物载体及其制备方法 |
| GB201223276D0 (en) | 2012-12-21 | 2013-02-06 | Ucb Pharma Sa | Antibodies and methods of producing same |
| GB201315487D0 (en) | 2013-08-30 | 2013-10-16 | Ucb Pharma Sa | Antibodies |
| GB201320066D0 (en) | 2013-11-13 | 2013-12-25 | Ucb Pharma Sa | Biological products |
| GB201409558D0 (en) | 2014-05-29 | 2014-07-16 | Ucb Biopharma Sprl | Method |
| GB201411320D0 (en) | 2014-06-25 | 2014-08-06 | Ucb Biopharma Sprl | Antibody construct |
| GB201412658D0 (en) | 2014-07-16 | 2014-08-27 | Ucb Biopharma Sprl | Molecules |
| GB201412659D0 (en) | 2014-07-16 | 2014-08-27 | Ucb Biopharma Sprl | Molecules |
| GB201506869D0 (en) | 2015-04-22 | 2015-06-03 | Ucb Biopharma Sprl | Method |
| GB201506870D0 (en) | 2015-04-22 | 2015-06-03 | Ucb Biopharma Sprl | Method |
| BR112017023158A2 (pt) | 2015-04-30 | 2018-07-24 | Harvard College | anticorpos anti-ap2 e agentes de ligação de antígeno para tratar distúrbios metabólicos |
| GB201508180D0 (en) | 2015-05-13 | 2015-06-24 | Ucb Biopharma Sprl | Antibodies |
| MA47395A (fr) | 2015-05-27 | 2019-12-11 | Ucb Biopharma Sprl | Méthode pour le traitement d'une maladie neurologique |
| TN2017000539A1 (en) | 2015-07-06 | 2019-04-12 | Ucb Biopharma Sprl | Tau-binding antibodies |
| GB201601073D0 (en) | 2016-01-20 | 2016-03-02 | Ucb Biopharma Sprl | Antibodies |
| GB201601075D0 (en) | 2016-01-20 | 2016-03-02 | Ucb Biopharma Sprl | Antibodies molecules |
| GB201601077D0 (en) | 2016-01-20 | 2016-03-02 | Ucb Biopharma Sprl | Antibody molecule |
| MX2018005031A (es) | 2015-10-27 | 2018-06-13 | Ucb Biopharma Sprl | Metodos de tratamiento con anticuerpos anti interleucina 17a/17f (il-17a/f). |
| GB201521391D0 (en) | 2015-12-03 | 2016-01-20 | Ucb Biopharma Sprl | Antibodies |
| GB201521389D0 (en) | 2015-12-03 | 2016-01-20 | Ucb Biopharma Sprl | Method |
| GB201521383D0 (en) | 2015-12-03 | 2016-01-20 | Ucb Biopharma Sprl And Ucb Celltech | Method |
| GB201521382D0 (en) | 2015-12-03 | 2016-01-20 | Ucb Biopharma Sprl | Antibodies |
| GB201521393D0 (en) | 2015-12-03 | 2016-01-20 | Ucb Biopharma Sprl | Antibodies |
| GB201522394D0 (en) | 2015-12-18 | 2016-02-03 | Ucb Biopharma Sprl | Antibodies |
| US11534496B2 (en) | 2016-06-07 | 2022-12-27 | The Brigham And Women's Hospital, Inc. | Compositions and methods relating to T peripheral helper cells in autoantibody-associated conditions |
| GB201610198D0 (en) | 2016-06-10 | 2016-07-27 | Ucb Biopharma Sprl | Anti-ige antibodies |
| JP2020500834A (ja) | 2016-08-26 | 2020-01-16 | エージェンシー フォー サイエンス，テクノロジー アンド リサーチ | マクロファージ刺激タンパク質受容体（又はＲＯＮ（Ｒｅｃｅｐｔｅｕｒ ｄ′Ｏｒｉｇｉｎｅ Ｎａｎｔａｉｓ））抗体及びその使用 |
| GB201616596D0 (en) | 2016-09-29 | 2016-11-16 | Nascient Limited | Epitope and antibodies |
| GB201621635D0 (en) | 2016-12-19 | 2017-02-01 | Ucb Biopharma Sprl | Crystal structure |
| WO2018183366A1 (en) | 2017-03-28 | 2018-10-04 | Syndax Pharmaceuticals, Inc. | Combination therapies of csf-1r or csf-1 antibodies and a t-cell engaging therapy |
| WO2018213665A1 (en) | 2017-05-19 | 2018-11-22 | Syndax Pharmaceuticals, Inc. | Combination therapies |
| GB201802486D0 (en) | 2018-02-15 | 2018-04-04 | Ucb Biopharma Sprl | Methods |
| US20220025351A1 (en) * | 2018-09-18 | 2022-01-27 | Kaneka Corporation | Production method for immobilized microorganisms and production method for amino acid using the same |
| WO2020079086A1 (en) | 2018-10-16 | 2020-04-23 | UCB Biopharma SRL | Method for the treatment of myasthenia gravis |
| WO2020197502A1 (en) | 2019-03-26 | 2020-10-01 | Aslan Pharmaceuticals Pte Ltd | Treatment employing anti-il-13r antibody or binding fragment thereof |
| GB201919062D0 (en) | 2019-12-20 | 2020-02-05 | Ucb Biopharma Sprl | Antibody |
| GB201919061D0 (en) | 2019-12-20 | 2020-02-05 | Ucb Biopharma Sprl | Multi-specific antibody |
| GB201919058D0 (en) | 2019-12-20 | 2020-02-05 | Ucb Biopharma Sprl | Multi-specific antibodies |
| GB202001447D0 (en) | 2020-02-03 | 2020-03-18 | Ucb Biopharma Sprl | Antibodies |
| WO2022079199A1 (en) | 2020-10-15 | 2022-04-21 | UCB Biopharma SRL | Binding molecules that multimerise cd45 |
| EP4237081A1 (de) | 2020-11-02 | 2023-09-06 | UCB Biopharma SRL | Verwendung von anti-trem1-neutralisierenden antikörpern zur behandlung neurodegenerativer erkrankungen von motoneuronen |
| EP4255926A1 (de) | 2020-12-07 | 2023-10-11 | UCB Biopharma SRL | Multispezifische antikörper und antikörperkombinationen |
| AU2021398385A1 (en) | 2020-12-07 | 2023-07-13 | UCB Biopharma SRL | Antibodies against interleukin-22 |
| WO2022186772A1 (en) | 2021-03-01 | 2022-09-09 | Aslan Pharmaceuticals Pte Ltd | TREATMENT OF ATOPIC DERMATITIS EMPLOYING ANTI-IL-13Rα1 ANTIBODY OR BINDING FRAGMENT THEREOF |
| WO2022186773A1 (en) | 2021-03-01 | 2022-09-09 | Aslan Pharmaceuticals Pte Ltd | TREATMENT OF ATOPIC DERMATITIS EMPLOYING ANTI-IL-13Rα1 ANTIBODY OR BINDING FRAGMENT THEREOF IN AN ALLERGIC POPULATION |
| EP4067381A1 (de) | 2021-04-01 | 2022-10-05 | Julius-Maximilians-Universität Würzburg | Neue tnfr2-bindende moleküle |
| IL308100A (en) | 2021-05-03 | 2023-12-01 | UCB Biopharma SRL | Antibodies |
| GB202111905D0 (en) | 2021-08-19 | 2021-10-06 | UCB Biopharma SRL | Antibodies |
| WO2023048650A1 (en) | 2021-09-27 | 2023-03-30 | Aslan Pharmaceuticals Pte Ltd | TREATMENT OF PRURITIS EMPLOYING ANTI-IL13Rα1 ANTIBODY OR BINDING FRAGMENT THEREOF |
| WO2023048651A1 (en) | 2021-09-27 | 2023-03-30 | Aslan Pharmaceuticals Pte Ltd | Method for treatment of moderate to severe atoptic dematitis |
| GB202115122D0 (en) | 2021-10-21 | 2021-12-08 | Dualyx Nv | Binding molecules targeting IL-2 receptor |
| WO2023075702A1 (en) | 2021-10-29 | 2023-05-04 | Aslan Pharmaceuticals Pte Ltd | Anti-il-13r antibody formulation |
| WO2023140780A1 (en) | 2022-01-24 | 2023-07-27 | Aslan Pharmaceuticals Pte Ltd. | Method of treating inflammatory disease |
| WO2023163659A1 (en) | 2022-02-23 | 2023-08-31 | Aslan Pharmaceuticals Pte Ltd | Glycosylated form of anti-il13r antibody |
| GB202210679D0 (en) | 2022-07-21 | 2022-09-07 | Dualyx Nv | Binding molecules targeting il-12rb2 |
| WO2024043837A1 (en) | 2022-08-26 | 2024-02-29 | Aslan Pharmaceuticals Pte Ltd | High concentration anti-il13r antibody formulation |
| WO2024054157A1 (en) | 2022-09-06 | 2024-03-14 | Aslan Pharmaceuticals Pte Ltd | Treatment for sleep loss or sleep disturbance in patients with dermatitis |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3925157A (en) * | 1972-07-12 | 1975-12-09 | Pfizer | Immobilized enzymes |
| GB1400468A (en) * | 1972-07-22 | 1975-07-16 | Beecham Group Ltd | Enzyme preparation and use thereof |
| US4732851A (en) * | 1982-03-16 | 1988-03-22 | Purification Engineering, Inc. | Immobilization of cells with a polyazetidine prepolymer |
| US4436813A (en) * | 1982-03-16 | 1984-03-13 | Purification Engineering, Inc. | Immobilized microbial cell composition for making L-aspartic acid |
| DK152764C (da) * | 1985-06-14 | 1988-10-03 | Novo Industri As | Fremgangsmaade til fremstilling af et immobiliseret enzymprodukt |
-
1987
- 1987-07-01 DK DK336987A patent/DK336987D0/da unknown
-
1988
- 1988-06-30 DE DE88306038T patent/DE3886280T2/de not_active Expired - Fee Related
- 1988-06-30 ES ES88306038T patent/ES2061656T3/es not_active Expired - Lifetime
- 1988-06-30 EP EP88306038A patent/EP0297912B1/de not_active Expired - Lifetime
- 1988-06-30 AT AT88306038T patent/ATE98689T1/de not_active IP Right Cessation
- 1988-07-01 WO PCT/DK1988/000108 patent/WO1989000195A1/en unknown
- 1988-07-01 JP JP63505497A patent/JP2641934B2/ja not_active Expired - Lifetime
- 1988-07-01 KR KR1019890700356A patent/KR970000186B1/ko not_active IP Right Cessation
-
1989
- 1989-03-01 DK DK097189A patent/DK160843C/da not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE3886280T2 (de) | 1994-03-31 |
| DE3886280D1 (de) | 1994-01-27 |
| EP0297912A3 (en) | 1990-01-10 |
| EP0297912A2 (de) | 1989-01-04 |
| DK336987D0 (da) | 1987-07-01 |
| DK160843B (da) | 1991-04-22 |
| JP2641934B2 (ja) | 1997-08-20 |
| DK97189D0 (da) | 1989-03-01 |
| JPH01503677A (ja) | 1989-12-14 |
| ES2061656T3 (es) | 1994-12-16 |
| WO1989000195A1 (en) | 1989-01-12 |
| EP0297912B1 (de) | 1993-12-15 |
| DK97189A (da) | 1989-03-01 |
| KR890701737A (ko) | 1989-12-21 |
| DK160843C (da) | 1991-10-14 |
| KR970000186B1 (ko) | 1997-01-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3886280D1 (de) | Immobilisierungsverfahren. | |
| KR870700647A (ko) | 디엔계중합체와 그 제조방법 및 이를 함유하는 고무 조성물 | |
| EP0138833A4 (de) | Methoden zur Ermittlung der Lebensfähigkeit von Zellen und Vorrichtung zu ihrer Durchführung. | |
| DE68922216D1 (de) | Zellenzuchtverfahren in bioreaktoren. | |
| EP0281368A3 (en) | Enzyme immobilization and bioaffinity separations with perfluorocarbon polymer-based supports | |
| DK521286A (da) | Modificerede, polymere overflader og fremgangsmaade til fremstilling deraf | |
| IT8821481A0 (it) | Processo ed apparato per la devolatilizzazione di soluzioni di polimeri. | |
| NO865206D0 (no) | Fremgangsmaate og apparat for fremstilling av skummende termoplastgjenstander. | |
| HU9300275D0 (en) | Method for binding emzyme in shape of crystal of spatial network structure | |
| PL267910A1 (en) | Constant catalyst applied for stereospecific polymerization of alfa-olefins,the method of its manufacture and the method of alfa-olefins polymerization in the presence of that catalyst | |
| DE3382425D1 (de) | Immobilisierte mikrobenzellen und verfahren zu deren herstellung und deren anwendung. | |
| ZA849758B (en) | Process for preparing oxirane-bearing polymer carriers for immobilizing enzymes and other materials bearing active hydrogen,and oxirane-bearing polymer carriers | |
| DE3779905D1 (de) | Zellkulturtraeger. | |
| GB2151636B (en) | Reactive polymer, method for manufacture thereof and use thereof | |
| DE3362885D1 (en) | Polymerizable, optically active polymer and process for preparing polymerizable polymer | |
| IL70840A (en) | Cell culture apparatus,immobilized cell composite and process for preparation of the composite | |
| AU8217387A (en) | Process and device for the cultivation of immobilized or adherent mammalian cells, and the use thereof in the preparation of proteins | |
| ATE90790T1 (de) | Verfahren zur herstellung einer festphasenmatrix. | |
| DE3676896D1 (de) | Verfahren zur herstellung von hexamethylcyclotrisilazan. | |
| EP0222289A3 (en) | Process for the immobilization of biological material, particulate coagulates containing an immobilized biological material and their use as catalysts | |
| EP0137205A3 (de) | Verfahren zur Herstellung von Polymeren in Teilchenform | |
| ES2059479T3 (es) | Procedimiento para preparar pregneno-oxazolinas. | |
| DE3271040D1 (en) | Carrier-fixed proteases and their use in biotechnology | |
| ES8506903A1 (es) | Procedimiento para preparar fibrina fijada a un soporte | |
| AU2989989A (en) | Cell culture apparatus and process using an immobilized cell composite |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |